Online ECHO Clinic | September 3, 2020
Presentation Title: Challenges in Addressing the Evolving Opioid Crisis During COVID-19
Dr. Marwan Haddad and Daniel Bryant, LPC, from the Weitzman Institute, shares information on how they have met their SUD patient needs during the COVID-19 pandemic.
Marwan Haddad, MD, is the Medical Director of the Center for Key Populations at Community Health Center, Inc. (CHC). He has led the CHC Project ECHO HIV, Hepatitis C, and Buprenorphine programs. He has taught and lectured at state and national conferences on HIV, HCV, buprenorphine and integrated care. He has published research on the integration of buprenorphine in community health centers examining both substance abuse as well as primary care outcomes.
Daniel Bryant, LPC